Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sally Beard

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Hypertension (Dallas, Tex. : 1979)|January 25, 2017
Proton Pump Inhibitors Decrease Soluble fms-Like Tyrosine Kinase-1 and Soluble Endoglin Secretion, Decrease Hypertension, and Rescue Endothelial DysfunctionKenji Onda, Stephen Tong, Sally Beard, et al.
Scientific Reports|October 20, 2021
NR4A2 expression is not altered in placentas from cases of growth restriction or preeclampsia, but is reduced in hypoxic cytotrophoblastNatasha de Alwis, Sally Beard, Natalie K Binder, et al.
Pregnancy Hypertension|July 29, 2021
LOX-1 expression is reduced in placenta from pregnancies complicated by preeclampsia and in hypoxic cytotrophoblastNatasha de Alwis, Sally Beard, Natalie K Binder, et al.
American Journal of Obstetrics and Gynecology|July 29, 2018
Esomeprazole to treat women with preterm preeclampsia: a randomized placebo controlled trialCatherine A Cluver, Natalie J Hannan, Erika van Papendorp, et al.
Scientific Reports|March 11, 2021
DAAM2 is elevated in the circulation and placenta in pregnancies complicated by fetal growth restriction and is regulated by hypoxiaNatasha de Alwis, Sally Beard, Natalie K Binder, et al.
Antioxidants (Basel, Switzerland)|September 23, 2022
Placental OLAH Levels Are Altered in Fetal Growth Restriction, Preeclampsia and Models of Placental DysfunctionNatasha de Alwis, Sally Beard, Natalie K Binder, et al.
BMC Medicine|May 23, 2020
Circulating mRNAs are differentially expressed in pregnancies with severe placental insufficiency and at high risk of stillbirthNatalie J Hannan, Owen Stock, Rebecca Spencer, et al.
Iscience|July 18, 2024
CHK1 inhibitor SRA737 is active in PARP inhibitor resistant and <i>CCNE1</i> amplified ovarian cancerHaineng Xu, Sarah B Gitto, Gwo-Yaw Ho, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 6, 2026
High-throughput drug screening identifies EGFR/MAPK pathway targeting sensitivities in organoid models of ovarian carcinosarcomaAndrew Farrell, Genevieve Dall, Cassandra J Vandenberg, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Hypertension (Dallas, Tex. : 1979)|January 25, 2017
Proton Pump Inhibitors Decrease Soluble fms-Like Tyrosine Kinase-1 and Soluble Endoglin Secretion, Decrease Hypertension, and Rescue Endothelial DysfunctionKenji Onda, Stephen Tong, Sally Beard, et al.
Scientific Reports|October 20, 2021
NR4A2 expression is not altered in placentas from cases of growth restriction or preeclampsia, but is reduced in hypoxic cytotrophoblastNatasha de Alwis, Sally Beard, Natalie K Binder, et al.
Pregnancy Hypertension|July 29, 2021
LOX-1 expression is reduced in placenta from pregnancies complicated by preeclampsia and in hypoxic cytotrophoblastNatasha de Alwis, Sally Beard, Natalie K Binder, et al.
American Journal of Obstetrics and Gynecology|July 29, 2018
Esomeprazole to treat women with preterm preeclampsia: a randomized placebo controlled trialCatherine A Cluver, Natalie J Hannan, Erika van Papendorp, et al.
Scientific Reports|March 11, 2021
DAAM2 is elevated in the circulation and placenta in pregnancies complicated by fetal growth restriction and is regulated by hypoxiaNatasha de Alwis, Sally Beard, Natalie K Binder, et al.
Antioxidants (Basel, Switzerland)|September 23, 2022
Placental OLAH Levels Are Altered in Fetal Growth Restriction, Preeclampsia and Models of Placental DysfunctionNatasha de Alwis, Sally Beard, Natalie K Binder, et al.
BMC Medicine|May 23, 2020
Circulating mRNAs are differentially expressed in pregnancies with severe placental insufficiency and at high risk of stillbirthNatalie J Hannan, Owen Stock, Rebecca Spencer, et al.
Iscience|July 18, 2024
CHK1 inhibitor SRA737 is active in PARP inhibitor resistant and <i>CCNE1</i> amplified ovarian cancerHaineng Xu, Sarah B Gitto, Gwo-Yaw Ho, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 6, 2026
High-throughput drug screening identifies EGFR/MAPK pathway targeting sensitivities in organoid models of ovarian carcinosarcomaAndrew Farrell, Genevieve Dall, Cassandra J Vandenberg, et al.
Pageof 5